德国慕尼黑分子成像方向博后职位招聘

The Technische Universität München (TUM) is seeking applications from highly motivated candidates for a Postdoc position in molecular imaging using novel PET-probes. The candidates will work in the DFG-funded Collaborative Research Center (SFB 824) entitled "Imaging for Selection, Monitoring and Individualization of Cancer Therapies". The specific subproject in the SFB 824 is focussed on therapy assessment in prostate cancer using novel probes for PET-imaging that reflect PI3K-AKT-mTORC- and AR- pathway activation.

The candidate will be involved in applying established and in developing new PET-probes and their applications to preclinical and clinical problems. The project is embedded in current advances in imaging and therapy of prostate cancer conducted at TUM. The project will be developed in close collaboration with the Chair of Pharmaceutical Radiochemistry and the Department of Urology. The candidate will be integrated in a team of experienced scientists from TUM Nuclear Medicine (PD Dr. Matthias Eiber), TUM Chair of Radiochemistry (Prof. Dr. Hans-Jürgen Wester) and TUM Urology (PD Dr. Tobias Maurer).

Position for a Postdoc available in the field of "Molecular imaging for therapy assessment in prostate cancer"

Qualifications:

• We accept applications from candidates having a PhD with excellent degrees in biology or chemistry.
• Practical experience in cell culture, flow cytometry and animal research including preclinical imaging is required (e.g. FELASA B or equivalent skills). Experience in application of radioactive probes and analysing image data is desired. The candidate is expected to supervise technical assistants and students.

Our offer:

• The position is initially limited to the current funding period of the SF824, which is 4 years. The TUMprovides access to excellent infrastructure for conducting cutting-edge research in the field of molecular imaging (e.g. TranslaTUM as core facility for preclinical research, preclinical PET/CT and PET/MRI, state-of-the art radiochemistry).